|
業務類別
|
Medical Instruments & Supplies |
|
業務概覽
|
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures |
| 公司地址
| 7555 Innovation Way, Mason, OH, USA, 45040 |
| 電話號碼
| +1 513 755-4100 |
| 傳真號碼
| +1 888 347-6403 |
| 公司網頁
| https://www.atricure.com |
| 員工數量
| 1350 |
| Mr. Michael H. Carrel |
Director, President and Chief Executive Officer |
美元 824.42K |
19/02/2026 |
| Mr. Salvatore Privitera, J.D. |
Chief Technical Officer |
-- |
07/04/2025 |
| Mr. Karl S. Dahlquist, J.D. |
Chief Legal Officer |
美元 430.10K |
07/04/2025 |
| Mr. Douglas J. Seith |
Chief Operating Officer |
美元 551.07K |
07/04/2025 |
| Mr. Justin J. Noznesky |
Chief Marketing and Strategy Officer |
美元 434.72K |
07/04/2025 |
| Ms. Angela L. Wirick |
Chief Financial Officer and Principal Accounting Officer |
美元 462.94K |
19/02/2026 |
| Dr. Vinayak Doraiswamy, PhD |
Chief Scientific Officer |
-- |
07/04/2025 |
|
|
| Ms. B. Kristine Johnson |
Independent Director |
19/02/2026 |
| Mr. Michael H. Carrel |
Director, President and Chief Executive Officer |
19/02/2026 |
| Mr. Sven A. Wehrwein |
Independent Director |
19/02/2026 |
| Ms. Karen N. Prange |
Independent Director |
19/02/2026 |
| Mr. Robert S. White |
Chairman of the Board |
19/02/2026 |
| Ms. Regina E. Groves |
Independent Director |
19/02/2026 |
| Ms. Maggie Yuen |
Independent Director |
19/02/2026 |
| Ms. Deborah H. Telman |
Independent Director |
19/02/2026 |
| Mr. Shlomo Nachman |
Independent Director |
19/02/2026 |
|
|
|
|
